lenvatinib mesilate

Italy

Drugs containing this active substance

  • KISPLYX

    It is used in combination with other medicines as a first-line treatment for adults with advanced renal cell carcinoma, or in combination with everolimus when other treatments have not been effective.

    Form: capsules, hard gelatin

    Active substance Dosage
    lenvatinib mesilate -

    ATC: L01EX08

    Manufacturer: EISAI GMBH

  • LENVATINIB ACCORD

    It is used alone for the treatment of progressive or advanced thyroid cancer in adults (when radioactive iodine has not been effective) and for liver cancer in adults who have not previously been treated with other specific anticancer drugs. It can also be used in combination with pembrolizumab for the treatment of advanced uterine cancer in adult women.

    Form: capsules, hard gelatin

    Active substance Dosage
    lenvatinib mesilate -

    ATC: L01EX08

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • LENVATINIB TEVA

    It is used for the treatment of progressive or advanced thyroid cancer in adults (when radioactive iodine has not been effective), for liver cancer in adults who have not received other specific anticancer treatments, and for advanced endometrial cancer in women (in combination with pembrolizumab).

    Form: capsules, hard gelatin

    Active substance Dosage
    lenvatinib mesilate -

    ATC: L01EX08

    Manufacturer: TEVA ITALIA S.R.L.